Scinai director Green Jay reports initial holdings

Scinai Immunotherapeutics Ltd. director Green Jay has reported initial holdings in connection with becoming an insider.

Rhea-AI Filing Summary

Scinai Immunotherapeutics Ltd. director Green Jay has reported initial holdings in connection with becoming an insider. The filing shows direct ownership of 50 American Depositary Shares, which are convertible at any time into 200,000 Ordinary Shares and have no expiration.

Green Jay also holds stock options over 1,000,000 Ordinary Shares and 8,000,000 Ordinary Shares at an exercise price of $0.0050 per share, expiring on August 24, 2033, plus options over 48,200,000 Ordinary Shares at an exercise price of $0.0004 per share, expiring on December 22, 2035. These options vest in installments between August 24, 2025 and December 22, 2027, subject to continued service.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Green Jay

Role Director

Type	Security	Shares	Price	Value
holding	American Depositary Shares	--	--	--
holding	Stock Option (right to buy)	--	--	--
holding	Stock Option (right to buy)	--	--	--
holding	Stock Option (right to buy)	--	--	--

Holdings After Transaction: American Depositary Shares — 200,000 contracts (Direct); Stock Option (right to buy) — 57,200,000 contracts (Direct)

Footnotes (5)

1. F1. Represents 50 American Depositary Shares, which are convertible at any time into 200,000 Ordinary Shares, at the holder's election and have no expiration
2. F2. The Ordinary Shares are represented by American Depositary Shares, each of which currently represents four thousand Ordinary Shares.
3. F3. The option vests in one installment on August 24, 2027, subject to the Reporting Person's continued service through such date.
4. F4. The option vests in three equal annual installments commencing August 24, 2025, subject to the Reporting Person's continued service through such dates.
5. F5. The option vests in three equal annual installments commencing December 22, 2026, subject to the Reporting Person's continued service through such dates.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider position does Green Jay hold at Scinai Immunotherapeutics (SCNI)?

Green Jay is identified as a director of Scinai Immunotherapeutics Ltd. in the Form 3. The filing establishes their status as a reporting person and lists current holdings in American Depositary Shares and multiple option grants over Ordinary Shares.

How many Scinai (SCNI) American Depositary Shares does Green Jay report?

Green Jay reports holding 50 American Depositary Shares, which are convertible into 200,000 Ordinary Shares at the holder’s election. Each American Depositary Share currently represents 4,000 Ordinary Shares and the ADSs have no expiration date under the disclosed terms.

What stock options over Scinai (SCNI) Ordinary Shares does Green Jay hold?

The filing lists options over 1,000,000 Ordinary Shares and 8,000,000 Ordinary Shares at an exercise price of $0.0050, plus options over 48,200,000 Ordinary Shares at $0.0004, with expirations in 2033 and 2035, respectively.

When do Green Jay’s Scinai (SCNI) stock options vest?

One option grant vests in a single installment on August 24, 2027. Another vests in three equal annual installments starting August 24, 2025, and a third vests in three equal annual installments starting December 22, 2026, all subject to continued service.

Does the Scinai (SCNI) Form 3 show Green Jay buying or selling shares?

The Form 3 does not report any buy or sell transactions. It classifies all entries as holdings with unknown transaction codes, indicating this filing primarily establishes Green Jay’s initial ownership positions rather than new market trades.

What is the exercise price of Green Jay’s Scinai (SCNI) options?

Green Jay’s options have exercise prices of $0.0050 per Ordinary Share for 9,000,000 underlying shares in total, and $0.0004 per Ordinary Share for 48,200,000 underlying shares, reflecting low strike prices set in the disclosed option awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 09:59 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Green Jay

(Last) (First) (Middle)

C/O SCINAI IMMUNOTHERAPEUTICS LTD.

JERUSALEM BIOPARK, 2ND FLOOR

(Street)

JERUSALEM 9112002

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Scinai Immunotherapeutics Ltd. [ SCNI ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
American Depositary Shares	(1)	(1)	Ordinary shares, no par value per share ("Ordinary Shares")(2)	200,000	(1)	D
Stock Option (right to buy)	(3)	08/24/2033	Ordinary Shares	1,000,000	$0.005	D
Stock Option (right to buy)	(4)	08/24/2033	Ordinary Shares	8,000,000	$0.005	D
Stock Option (right to buy)	(5)	12/22/2035	Ordinary Shares	48,200,000	$0.0004	D

Explanation of Responses:

1. Represents 50 American Depositary Shares, which are convertible at any time into 200,000 Ordinary Shares, at the holder's election and have no expiration

2. The Ordinary Shares are represented by American Depositary Shares, each of which currently represents four thousand Ordinary Shares.

3. The option vests in one installment on August 24, 2027, subject to the Reporting Person's continued service through such date.

4. The option vests in three equal annual installments commencing August 24, 2025, subject to the Reporting Person's continued service through such dates.

5. The option vests in three equal annual installments commencing December 22, 2026, subject to the Reporting Person's continued service through such dates.

Remarks:

Exhibit 24 - Power of Attorney.

	/s/ Amir Reichman, Attorney-in-Fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)